dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:30:49Z
dc.date.available2014-05-27T11:30:49Z
dc.date.created2014-05-27T11:30:49Z
dc.date.issued2013-10-01
dc.identifierGynecological Endocrinology, v. 29, n. 10, p. 921-925, 2013.
dc.identifier0951-3590
dc.identifier1473-0766
dc.identifierhttp://hdl.handle.net/11449/76766
dc.identifier10.3109/09513590.2013.819084
dc.identifierWOS:000324258500011
dc.identifier2-s2.0-84883567770
dc.identifier4155170574788417
dc.description.abstractObjective: To compare estimation of cardiovascular risk using the Framinghan Risk Score (FRS) and the presence of the metabolic syndrome (MetS) in postmenopausal women to prevent primary cardiovascular disease (CVD). Methods: This cross-sectional study included 497 Brazilian women (aged 45 years and amenorrhea >12months). Cardiovascular risk was calculated using the FRS that includes age, total cholesterol, HDL, systolic blood pressure and smoking status. Women showing three or more of the following criteria were diagnosed with MetS: waist circumference (WC) >88cm, blood pressure 130/85mmHg, triglycerides 150mg/dl, HDL<50mg/dl and glucose 100mg/dl. For statistical analysis, the Chi-square, Fisher's exact, and logistic regression (odds ratio-OR) were used. Results: The mean age was 55.3±7.0 years and time since menopause 7.2±5.9 years. Based on FRS, 72.4% of women were classified as low-risk, 16.5% moderate risk and 11.1% a high-risk. MetS was identified in 40% of the women, and 46.2% were considered of moderate risk for CVD, while 84.9% of those without MetS were classified as low-risk (p<0.001). The risk for CVD increased significantly with age at menopause (OR1.10; 95% CI, 1.04-1.17), time since menopause (OR1.13; 95% CI, 1.08-1.18), elevated triglycerides (OR1.03; 95% CI, 1.0-1.10) and presence of MetS (OR1.72; 95% CI 1.48-1.84). Conclusions: By using only FRS to estimate cardiovascular risk, a substantial number of postmenopausal women showing evidence of MetS were not identified, even though women with MetS are at higher risk of CVD. © 2013 Informa UK Ltd.
dc.languageeng
dc.relationGynecological Endocrinology
dc.relation1.453
dc.relation0,649
dc.relation0,649
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectCardiovascular disease
dc.subjectFraminghan risk score
dc.subjectMenopause
dc.subjectMetabolic syndrome
dc.subjectcholesterol
dc.subjectglucose
dc.subjecthigh density lipoprotein
dc.subjectlow density lipoprotein
dc.subjecttriacylglycerol
dc.subjectadult
dc.subjectamenorrhea
dc.subjectcardiovascular disease
dc.subjectcardiovascular risk
dc.subjectcholesterol blood level
dc.subjectcomparative study
dc.subjectcross-sectional study
dc.subjectfemale
dc.subjectFramingham risk score
dc.subjectglucose blood level
dc.subjecthigh risk population
dc.subjecthuman
dc.subjectimmobilization
dc.subjectlipoprotein blood level
dc.subjectlow risk population
dc.subjectmajor clinical study
dc.subjectmenopause
dc.subjectmetabolic syndrome X
dc.subjectphysical activity
dc.subjectpostmenopause
dc.subjectpriority journal
dc.subjectsmoking
dc.subjectsystolic blood pressure
dc.subjecttriacylglycerol blood level
dc.subjectwaist circumference
dc.titleDifferent tools for estimating cardiovascular risk in Brazilian postmenopausal women
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución